Work

Pre-treatment endogenous interleukin-1 receptor antagonist (IL-1Ra) levels in metastatic colorectal cancer (mCRC) patients are associated with clinical outcomes after anti-interleukin-1a therapy (MABp1)

Year: 2017

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx261.280

Authors: Razelle Kurzrock, Tamas Hickish, Lucjan Wyrwicz, Thierry André, Tomasz Sarosiek, Judit Kocsis, Radim Nemecek, Qian Wu, Prasant Mohanty, Mike Stecher, John Simard, Charles Dinarello

Institutions: University of California San Diego, Royal Bournemouth Hospital, The Maria Sklodowska-Curie National Research Institute of Oncology, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, University of Debrecen, Masaryk Memorial Cancer Institute, XBiotech (United States), Radboud University Medical Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2733496156

FWCI:

Cites:

Cited by:

Related to: 10